TOP STORIES

• BUSINESS Ono President Confident of Validity of Company’s Argument on Opdivo Royalties
  June 19, 2020

• REGULATORY Chuikyo Doctor Reps Nix Drug Price Survey Discussion, Say It Should Only Come after Govt’s Go/No-Go Decision
  June 18, 2020

• BUSINESS 10 Foreign Makers in Japan Grow Above Market with 5.5% Sales Rise in 2019
  June 17, 2020

• REGULATORY MHLW to Propose Two-Third Sampling Rate for Wholesaler Survey for Off-Year Drug Re-Pricing; Go/No-Go Debate to Continue
  June 16, 2020

• BUSINESS 26 Japan Drug Makers Generate 56.4% of Sales Overseas in FY2019, Shire Buy Gives Boost: Tally
  June 15, 2020

• ORGANIZATION New Special Rule for “Indication Change” Re-Pricing Significantly Lacks Predictability: FPMAJ
  June 12, 2020

• REGULATORY Industry Says There’s No Way Off-Year Drug Price Survey Can Be Done; Chuikyo Healthcare Reps Agree but Payers Don’t
  June 11, 2020

• ORGANIZATION Daiichi Sankyo CEO Manabe Set to Gain Lobbying Experience as FPMAJ Vice Chair, Chairman Seat Eyed for 2021
  June 10, 2020

• REGULATORY Stable Supply Debate Set to Heat Up in Japan, Scientific Societies to Select Key Drugs by June-End
  June 9, 2020

• BUSINESS Big 3 Generic Firms Log 5.9% Sales Increase in FY2019, with Contraction in Overseas Business: Jiho Tally
  June 9, 2020

• ORGANIZATION Japan Pharma Trade Group Nudges Govt to Postpone Off-Year Re-Pricing
  June 8, 2020

• ACADEMIA Remdesivir Not Used as Severe Cases Decreased, Avigan/Alvesco Given to Several Dozen Patients: TMDU Hospital
  June 5, 2020

• BUSINESS Kyowa Kirin Looks to Make Crysvita 1st In-House Blockbuster, Sees 100 Billion Yen Target “Not Unachievable”
  June 5, 2020

• ORGANIZATION API/Intermediate Imports from India Still Stalled, Traders’ Group Calls for Govt Schemes
  June 4, 2020

• BUSINESS Kyowa Hakko Bio’s GMP Breach Triggers Shipment Curbs, Stockouts at Astellas, Kowa; Impact Could Reverberate Further
  June 3, 2020

• BUSINESS 15 Drug Makers See 3.6% Negative Growth in Japan in FY2020 as Re-Pricing, Generic Entries Weigh: Jiho Tally
  June 2, 2020

• BUSINESS 6 Japan Drug Makers Net 20% Growth in China Biz Despite COVID-19 Woes
  June 1, 2020

• REGULATORY Oral Semaglutide Clears MHLW Panel, Now in Line for June Approval
  June 1, 2020

• ACADEMIA Japan to Join NIH’s Remdesivir-Baricitinib Combo Trial for COVID-19
  June 1, 2020

• BUSINESS Sanofi Japan Introduces 2-Week-Rule before Getting Back to Full Operations after COVID-19 Emergency Lift
  May 29, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 105
• 106
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• …
• Next ›
• 最終 »